NCT06209970View on ClinicalTrials.gov

35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal Cancer

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

March 5, 2024

Conditions
Cancer Pain
Interventions
DRUG

HA35

All the freshly made HA35 or B-HA samples were diluted to a final concentration of 5 mg/ml. The filter membrane with 220nm pore size was used to filter freshly made HA35 or B-HA injection in order to test its human tissue permeability as \<220nm nino-particle.

Trial Locations (1)

Unknown

Qingdao Huinorde Science and Technology Co.,Ltd, Qingdao

All Listed Sponsors
lead

Nakhia Impex LLC

INDUSTRY

NCT06209970 - 35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal Cancer | Biotech Hunter | Biotech Hunter